v3.26.1
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Revenue $ 7,814 $ 4,071 $ 12,508 $ 8,138
Costs and expenses        
Cost of revenue 3,495 2,282 5,883 4,244
Research and development 3,548 1,958 7,062 3,515
Selling, general, and administrative 912 606 1,658 1,099
Restructuring charges (credits) 2 190 (9) 194
Impairment 0 5 0 29
Total costs and expenses 7,957 5,041 14,594 9,081
Loss from operations (143) (970) (2,086) (943)
Interest expense (related party of $327 and $— for the three months ended June 30, 2026 and 2025, respectively, and $513 and $— for the six months ended June 30, 2026 and 2025, respectively) (629) (411) (1,293) (858)
Interest income 340 98 553 215
Other income (expense), net (86) 413 (1,962) 202
Loss before income taxes (518) (870) (4,788) (1,384)
Provision for income taxes 23 138 29 152
Net loss (541) (1,008) (4,817) (1,536)
Net loss attributable to shareholders - basic (541) (1,008) (5,488) (1,536)
Net loss attributable to shareholders - diluted $ (541) $ (1,008) $ (5,488) $ (1,536)
Net loss per share of common stock attributable to common shareholders        
Basic (in USD per share) $ (0.09) $ (0.34) $ (1.12) $ (0.53)
Diluted (in USD per share) $ (0.09) $ (0.34) $ (1.12) $ (0.53)
Weighted average shares used in computing net loss per share of common stock        
Weighted average shares of common stock outstanding - basic (in shares) 5,864 2,929 4,879 2,902
Weighted average shares of common stock outstanding - diluted (in shares) 5,864 2,929 4,879 2,902